N7: evaluation of maximal chemotherapy dose intensity plus monoclonal antibody 3F8 in the treatment of neuroblastoma
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Antineoplastics; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Filgrastim; Filgrastim; Monoclonal antibody 3F8 I-131; Vincristine
- Indications Neuroblastoma
- Focus Therapeutic Use
- 17 Dec 2009 Actual end date (Sep 2004) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Sep 2005 New trial record.